DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Liso-cel Proves Safe And Effective For R/R LBCL Patients Aug 30, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Subcutaneous Epcoritamab Achieved Complete Remissions In R/R LBCL Aug 24, 2023
Lymphoma,MCL (Mantle Cell Lymphoma) Impact of Rituximab Maintenance on Young Pts With MCL Aug 21, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) AUTO4 Shows Tolerance in Patients With TRBC1-Positive PTCL Aug 21, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Rituximab Plus Ibrutinib Show Efficacy and Safety in Untreated MZL Aug 18, 2023
FL (Follicular Lymphoma),Lymphoma Bone Marrow Biopsies in NCI-NCTN Follicular Lymphoma Trials: Response Relevance Evaluated Jun 01, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Long-term Outcomes of Axi-cel CAR T-cell Therapy in iNHL Patients - ZUMA-5 Study Mar 01, 2023
Lymphoma,MZL (Marginal Zone Lymphoma) Research on Pirtobrutinib Safe and Effective for RT Patients with DLBCL Mar 01, 2023